Diagnostics chain Dr Lal PathLabs posts Rs 58 crore profit for Dec quarter

Diagnostics chain Dr Lal PathLabs Ltd on Thursday reported a consolidated net profit of Rs 58.2 crore in the third quarter ended in December 2021.

Dr. Lal Pathlabs
Dr. Lal Pathlabs
Press Trust of India New Delhi
1 min read Last Updated : Feb 10 2022 | 8:13 PM IST

Diagnostics chain Dr Lal PathLabs Ltd on Thursday reported a consolidated net profit of Rs 58.2 crore in the third quarter ended in December 2021.

The company had posted a consolidated net profit of Rs 95.9 crore in the same quarter last fiscal, Dr Lal PathLabs said in a regulatory filing.

Consolidated revenue from operations during the quarter under review stood at Rs 496.9 crore. It was at Rs 452.4 crore in the year-ago period, it added.

The results include that of Suburban Diagnostics with effect from November 12, 2021, and hence is not strictly comparable with previous year, the company said.

Covid and allied contributed 11.8 per cent to revenue in Q3 FY22 with 5.8 lakh RTPCR tests, it added.

Total expenses during the third quarter were at Rs 427.5 crore, up from Rs 337 crore in the year-ago quarter, Dr Lal PathLabs said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Dr Lal PathLabsQ3 results

First Published: Feb 10 2022 | 8:13 PM IST

Next Story